Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis.

Published in: The Journal of pharmacy and pharmacology (2017)

Amphotericin B-Intralipid was identified as safer, cost-saving treatment in comparison with other formulations.

Keyphrases